Regulatory Approvals

Roivant Wins Approval for the First Oral Dermatomyositis Drug. How Large is the Opportunity?

By

Regulatory Approvals — Roivant Wins Approval for the First Oral Dermatomyositis Drug. How Large is the Opportunity?  Yahoo Finance

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. September 8, 2026.

By

Related Post

Regulatory Approvals

FDA Approves Camizestrant for ESR1 -Mutated Breast Cancer

Regulatory Approvals

Hamamatsu Stock Faces Questions After FDA Clears More Slide Scanners

Regulatory Approvals

FDA approves AstraZeneca’s oral SERD for breast cancer despite negative adcomm vote

Financial News For All

Mergers & Acquisitions

WaFd Enters $3.9B Reverse Merger Transaction with EverBank Financial

Mergers & Acquisitions

Uber’s $15 Billion Takeover Bid Gets Delivery Hero Board Backing

Labor

Walkout and Rally Recap + Call Bob-A-Thon Continues All Week

Labor

Eiffel Tower closed due to strike after female staff allegedly removed for religious group